Leadership preparing for a possible pandemic of swine influenza vaccine and bulk buying drugs for the treatment of this disease.
What do you think? say
Pharmaceutical company GlaxoSmithKline acknowledges that arose due to the threat of a pandemic panic, she managed to significantly increase their revenues. Already in September, GlaxoSmithKline offers the world's first vaccine against swine influenza. The UK government has ordered 60 million doses of the drug. Many countries are also produced by GlaxoSmithKline buy drug Relenza, which helps to cope with the symptoms of the disease. This means that Glaxo, like many other pharmaceutical companies do not earn badly for swine flu. From the beginning, this concern has sold British Medical drugs worth 3 billion pounds. The head of GlaxoSmithKline, Andrew Witty reported that the company is ready to fight the pandemic. According to him, thanks to investment, which over the past three and a half years were billion pounds, the plant may soon increase production. The pharmaceutical company Roche Holding AG, in turn, claimed to start programs to reduce the price of its drug Tamiflu, also used for the treatment of swine influenza in developing countries by half, and allowed pay money for it for several years. Medicine will be 5 to 6 euros, while the standard price per pack of Tamiflu 12 euros. The program will be open to 70 members of the Global Alliance for Vaccines and Immunization. The exception is India, which sold the drug analogue Tamiflu. As previously reported, the cost of potential Market vaccination against swine influenza is estimated at 10-20 billion dollars.
News by topic:
Previous and next news :